Abstract:Abdominal aortic aneurysm (AAA) is a dangerous condition affecting the aorta. Macrophage pyroptosis, phenotypic transformation, and apoptosis of aortic smooth muscle cells (ASMCs) are pivotal mechanisms in AAA pathogenesis. This study explores how Gasdermin B (GSDMB) regulates macrophage non-canonical pyroptosis and its impact on the phenotypic transformation and apoptosis of ASMCs, thereby unveiling the role of GSDMB in AAA pathogenesis. Immunofluorescence analysis was used to assess the expression levels and localization of GSDMB, cysteinyl aspartate-specific protease-4 (Caspase-4), and N-terminal of cleaved GSDMD (N-GSDMD) in AAA tissues. A cell model that mimics macrophage non-canonical pyroptosis was established by treating THP-1 cells with lipopolysaccharide (LPS). THP-1 cells with reduced or increased GSDMB were generated using small interfering RNA (siRNA) or plasmids. Co-culture experiments involving THP-1 cells and HASMCs were conducted to explore the impact of GSDMB on HASMCs. The mitochondrial reactive oxygen species (mtROS) scavenger Mito-TEMPO lowered mtROS levels in THP-1 cells. Our findings revealed that GSDMB was significantly upregulated in AAA macrophages, which was accompanied by robust non-canonical pyroptosis. THP-1 cells showed non-canonical pyroptosis in response to LPS, which was accompanied by an increase in GSDMB. Further research demonstrated that altering GSDMB, either by knockdown or overexpression, can affect macrophage non-canonical pyroptosis as well as the phenotypic transformation and apoptosis of HASMCs. LPS-induced non-canonical pyroptosis in THP-1 cells was associated with an increase in mtROS, whereas Mito-TEMPO effectively decreased non-canonical pyroptosis and the expression of GSDMB. These findings suggest that GSDMB plays a role in AAA macrophage non-canonical pyroptosis, which influences the phenotypic transformation and apoptosis of HASMCs. The mtROS-Dynamin-Related Protein 1 (Drp1) axis is likely to regulate the GSDMB-mediated non-canonical pyroptosis.

The Regulation and Modification of GSDMD Signaling in Diseases

Research Progress in Gasdermin Family Proteins and Their Association with Diseases

The gasdermin family: emerging therapeutic targets in diseases

Precise Orchestration of Gasdermins' Pore-Forming Function by Posttranslational Modifications in Health and Disease

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Role of gasdermin D in inflammatory diseases: from mechanism to therapeutics

Gasdermin D in pyroptosis

GSDMD in regulated cell death: A novel therapeutic target for sepsis

E3 Ubiquitin Ligase SYVN1 is a Key Positive Regulator for GSDMD-mediated Pyroptosis

Gasdermins: a dual role in pyroptosis and tumor immunity

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis

Genetic and Pharmacological Targeting of GSDMD Ameliorates Systemic Inflammation in Macrophage Activation Syndrome

Gasdermin E: A Prospective Target for Therapy of Diseases

Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization.

Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition.

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles

GSDMB involvement in the pathogenesis of abdominal aortic aneurysm through regulation of macrophage non-canonical pyroptosis

Palmitoylation at a Conserved Cysteine Residue Facilitates Gasdermin D-mediated Pyroptosis and Cytokine Release

To die or not to die: Gasdermins in intestinal health and disease

Intestinal Gasdermins for regulation of inflammation and tumorigenesis